I guess we still wait for an answer to "does it work". But it does at least seem they have massively improved the chances by deciding to target these eye diseases rather than more generalised parts of the body such as muscles. I'm "still" no scientist but targeting areas within the eye at least initially with the cell penetrative treatments seemed like a great way to limit off target absorption. Also seems like a much smaller and more specific target they have chosen so I am assuming they get more effect in more specific required area than if they were trying to treat something in the general body mass?
- Forums
- ASX - By Stock
- PYC
- Ann: PYC Expands US Executive Leadership Team
Ann: PYC Expands US Executive Leadership Team, page-11
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PYC (ASX) to my watchlist
(20min delay)
|
|||||
Last
17.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $793.2M |
Open | High | Low | Value | Volume |
17.0¢ | 17.3¢ | 16.5¢ | $127.4K | 753.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
13 | 319876 | 16.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
17.0¢ | 27378 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
13 | 319876 | 0.165 |
14 | 372321 | 0.160 |
9 | 318578 | 0.155 |
12 | 358614 | 0.150 |
4 | 120703 | 0.145 |
Price($) | Vol. | No. |
---|---|---|
0.170 | 27378 | 2 |
0.175 | 331491 | 8 |
0.180 | 842550 | 10 |
0.185 | 1267256 | 14 |
0.190 | 680193 | 11 |
Last trade - 13.43pm 08/10/2024 (20 minute delay) ? |
Featured News
PYC (ASX) Chart |